Joint Formulary & PAD

Formulary Search

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Search

A-Z of Drugs : A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

A-Z of Drugs

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Search Results : Obsessive compulsive disorder (OCD) (Clomipramine hydrochloride - Obsessive compulsive disorder (OCD))

Records returned : 12 (on 26 Jan 2026 at 09:49:33). Return to search results for ' Obsessive compulsive disorder (OCD) '.

Show Icon and Status Keys

Drug
Indication
Status
Restrictions/Comments
Formulary Status
Links
Status :
Green (see narrative)
Formulations :
  • Capsules
Restrictions / Comments:

Important

For OCD, NICE recommend initial treatment should be with one of  the following: fluoxetine, fluvoxamine, paroxetine, sertraline or citalopram (off label).

Clomipramine should be considered in the treatment of adults with OCD or BDD after an adequate trial of at least 1 SSRI has been ineffective or poorly tolerated, if the patient prefers clomipramine or has had a previous good response to it.

 
Links :
SPC
Status :
Green
Formulations :
  • Oral drops
  • Tablets
Restrictions / Comments:

Important
Preferred

Off-label use.

Dose adjustment required for liquid (10mg tablet = 8mg Oral Drops (4 drops) - see SPC for dose equivalence)

 
Links :
Off Label
SPC
Status :
Green
Formulations :
  • Tablets
Restrictions / Comments:

Important

For OCD, NICE recommend initial treatment should be with one of  the following: fluoxetine, fluvoxamine, paroxetine, sertraline or citalopram (off label).

 
Links :
SPC
Status :
Green (see narrative)
Formulations :
  • Oral drops
  • Oro-dispersible tablets
Restrictions / Comments:

Important

For OCD, NICE recommend initial treatment should be with one of  the following: fluoxetine, fluvoxamine, paroxetine, sertraline or citalopram (off label).

For use where ordinary tablets are not suitable.

 
Links :
SPC
Status :
Green
Formulations :
  • Capsules
Restrictions / Comments:

Preferred
 
Links :
SPC
Status :
Green (see narrative)
Formulations :
  • Dispersible tablets
  • Oral solution
Restrictions / Comments:

Important

Fluoxetine dispersible tablets are the more cost effective option in patents without dysphagia.

Fluoxetine oral solution and dispersible tablets are clinically interchangable for oral use.

 
Links :
SPC
Status :
Green
Formulations :
  • Tablets
Restrictions / Comments:

Preferred
 
Links :
SPC
Status :
Green
Formulations :
  • Tablets
Restrictions / Comments:

Preferred
 
Links :
SPC
Status :
Green
Formulations :
  • Tablets
Restrictions / Comments:

Preferred
 
Links :
SPC
Status :
Green (see narrative)
Formulations :
  • Oral suspension
Restrictions / Comments:

Important

50mg/5ml oral suspension

Reserve for patients who require a liquid formulation only where:
- an alternative SSRI liquid (citalopram drops, escitalopram drops or fluoxetine liquid) are not suitable
- the patients is unable to manage the dilution of sertraline 100mg/5ml concentrate oral solution

 
Links :
R
SPC
Status :
Green (see narrative)
Formulations :
  • Oral solution
Restrictions / Comments:

Important

100mg/5ml concentrate for oral solution - REQUIRES DILUTION

Reserve for patients who require a liquid formulation where an alternative SSRI liquid (citalopram drops, escitalopram drops or fluoxetine liquid) are not suitable.
Note – Dose must be diluted with 120mL of water, ginger ale, lemon/lime soda, lemonade or orange juice.

Dilution instructions are provided in the patient information leaflet: Sertraline 100mg/5ml concentrate for oral solution PIL

 
Links :
SPC
Status :
Non Formulary
Formulations :
  • Capsules
Restrictions / Comments:

 
Links :
SPC